On your Form C, there is significant Revenue/Sales for current and prior fiscal years. Curious how are you acquiring revenue/sales at this point? via Grants?

Yes, grants are considered revenue for tax purposes.

if the drug already exists for another indication and is, perhaps, generic, why should a physician prescribe your brand name drug instead of the same chemical under its pre-existing name?

Good question. The active drug in WST-057 was never approved in the US (and thus not a generic in the US) but approved in other countries as a pill. It has however been shown to be very safe over the decades of use - which is why we chose this drug - "to take safety concerns off the table". Irrespective, we've discovered that in its original formulation, as a pill, it will be ineffective. A topical formulation - WST057 - treats the disease locally and likely far saf...

How can I become part of the clinical trial? I'd fund the whole freaking thing if it works.

We would love to be able to get everyone in our clinical trial - we too are impatient for a therapy. We are doing everything we can to accelerate approval, including running as many trials as we can to speed up the process. I was recently at a conference where one of the business development folks told me that he did not believe there is a market for reversing nerve damage, i.e., nerve growth, function, etc. This is the reason we need support from our community, and one ...

if the drug has been approved in other countries for some other use, why was it never approved for that use in the u.s.?

It was not very effective for its original indication, peptic ulcers. And not that long after, all the other ulcer drugs came out on the market (Nexium, Prilosec, etc.) - which were very effective. The originating company abandoned the product for marketing purposes. But over the last several decades, it has proven out to be safe without the long term concerns now surfacing with other drugs.

If I know someone with pn, how can I get them involved in the clinical testing? If they have success I and they would be willing to invest.

We will be recruiting for our study in Canada soon. Our goal is to begin trials in the United States within a year, with the main objective to start a large pivotal study soon thereafter. I cannot guarantee acceptance into any trials but we are doing everything we can to get drugs (safe, effective and impactful) to patients ASAP. NOTE, we do have newsletters (both for investors and patients) that will keep individuals up to date. Please sign up at our website (www....

WinSanTor Updates, Team, and Funding Progress | Wefunder, Home of the Community Round

1

Drug regenerating peripheral nerves (humans) - combating direct cause of peripheral neuropathy

2

Repurposed medication w/ UNPARALLELED safety profile in FINAL phase (PH3) of clinical studies (DPN)

3

UNMET need affecting 100s of millions, ignored/neglected by industry, e.g., few, if any, competitors

4

VALIDATED science rewarded by innovation grants (>$40M) and licensing deal (>$200M + royalty)

5

Strong economic MOAT (the top KOLs, patents & other intellectual property, partners and strategy)

6

CEO's past companies were snatched by tech giants Qualcomm and Apple, tech now standards in industry

7

Industry ICONS lead our board, driving disruptive and transformative changes in healthcare

8

LAST crowdfunding investment opportunity before drug approval and IPO (~2-3 years)

WinSanTor

Developing The First Disease Modifying Drug to Regenerate Peripheral Nerves

$707,002

Highlights

Team

Memo

WinSanTor

Quick facts

Team profiles

Featured investor profiles

$707,002

Highlights

Related company links

Team

Memo